journal article·2019-03Open access

Self‐Assembly of Therapeutic Peptide into Stimuli‐Responsive Clustered Nanohybrids for Cancer‐Targeted Therapy

Wangxiao He, Simeng Wang, Jin Yan, Yiping Qu, Liang Jin, Fang Sui, Yujun Li, Weiming You, Guang Yang, Qi Yang, Meiju Ji, Yongping Shao, Peter X. Ma, Wuyuan Lu, Peng Hou

Advanced Functional Materials· Volume 29· Issue 10

Abstract

Abstract Clinical translation of therapeutic peptides, particularly those targeting intracellular protein–protein interactions (PPIs), has been hampered by their inefficacious cellular internalization in diseased tissue. Therapeutic peptides engineered into nanostructures with stable spatial architectures and smart disease targeting ability may provide a viable strategy to overcome the pharmaceutical obstacles of peptides. This study describes a strategy to assemble therapeutic peptides into a stable peptide–Au nanohybrid, followed by further self‐assembling into higher‐order nanoclusters with responsiveness to tumor microenvironment. As a proof of concept, an anticancer peptide termed β‐catenin/Bcl9 inhibitors is copolymerized with gold ion and assembled into a cluster of nanohybrids (pCluster). Through a battery of in vitro and in vivo tests, it is demonstrated that pClusters potently inhibit tumor growth and metastasis in several animal models through the impairment of the Wnt/β‐catenin pathway, while maintaining a highly favorable biosafety profile. In addition, it is also found that pClusters synergize with the PD1/PD‐L1 checkpoint blockade immunotherapy. This new strategy of peptide delivery will likely have a broad impact on the development of peptide‐derived therapeutic nanomedicine and reinvigorate efforts to discover peptide drugs that target intracellular PPIs in a great variety of human diseases, including cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Peptidase Inhibition and Analysis · Supramolecular Self-Assembly in Materials · Chemical Synthesis and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory for Tumor Precision Medicine of Shaanxi Province and Department of Endocrinology The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061 P. R. China

Center for Translational Medicine Key Laboratory of Biomedical Information Engineering of Ministry of Education School of Life Science and Technology and Frontier Institute of Science and Technology Xi'an Jiaotong University Xi'an 710049 P. R. China

Institute of Human Virology and Department of Biochemistry and Molecular Biology University of Maryland School of Medicine Baltimore MD 21201 USA

Department of Biologic and Materials Sciences Department of Biomedical Engineering, Macromolecular Science and Engineering Center Department of Materials Science and Engineering University of Michigan Ann Arbor MI 48109 USA

Department of Infectious Diseases The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061 P. R. China

Department of Oncology BenQ Medical Center Nanjing Medical University Nanjing 210029 P. R. China

Center for Translational Medicine The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061 P. R. China

Funding

National Institutes of Health · National Natural Science Foundation of China

References (63)

Show source-provided references
1. 10.1038/nrd368010.1038/nrd3680 ↗
2. 10.1038/nrd.2017.11110.1038/nrd.2017.111 ↗
3. 10.1038/nrc369010.1038/nrc3690 ↗
4. 10.1016/j.drudis.2014.10.00310.1016/j.drudis.2014.10.003 ↗
5. 10.1039/C7CS00536A10.1039/C7CS00536A ↗
6. 10.1039/C4CC08565E10.1039/C4CC08565E ↗
7. Sewald N. · 2015
8. 10.1021/acsnano.8b0008110.1021/acsnano.8b00081 ↗
9. 10.1016/j.biomaterials.2015.04.04110.1016/j.biomaterials.2015.04.041 ↗
10. 10.1016/j.biomaterials.2018.03.02510.1016/j.biomaterials.2018.03.025 ↗
11. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
12. 10.1021/nn200809t10.1021/nn200809t ↗
13. 10.1021/ja209981n10.1021/ja209981n ↗
14. 10.1021/ja205712a10.1021/ja205712a ↗
15. 10.1063/1.483687510.1063/1.4836875 ↗
16. 10.1002/ddr.2006610.1002/ddr.20066 ↗
17. 10.1002/smll.20040009310.1002/smll.200400093 ↗
18. 10.1146/annurev-med-040210-16254410.1146/annurev-med-040210-162544 ↗
19. 10.1039/C7CS00877E10.1039/C7CS00877E ↗
20. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
21. 10.1038/nbt.333010.1038/nbt.3330 ↗
22. 10.1016/S0092-8674(02)00679-710.1016/S0092-8674(02)00679-7 ↗
23. 10.1038/nrd423310.1038/nrd4233 ↗
24. 10.1016/j.cell.2006.10.01810.1016/j.cell.2006.10.018 ↗
25. 10.1146/annurev.cellbio.20.010403.11312610.1146/annurev.cellbio.20.010403.113126 ↗
26. 10.1038/ncb114110.1038/ncb1141 ↗
27. 10.1242/jcs.0286410.1242/jcs.02864 ↗
28. 10.1016/j.molcel.2006.09.00110.1016/j.molcel.2006.09.001 ↗
29. 10.1126/scitranslmed.300380810.1126/scitranslmed.3003808 ↗
30. 10.1021/jp983052810.1021/jp9830528 ↗
31. 10.1021/jp014259v10.1021/jp014259v ↗
32. 10.1016/j.carbpol.2006.11.00610.1016/j.carbpol.2006.11.006 ↗
33. 10.1021/acsnano.5b0201710.1021/acsnano.5b02017 ↗
34. 10.1021/acsnano.6b0232610.1021/acsnano.6b02326 ↗
35. 10.1021/cr800409e10.1021/cr800409e ↗
36. 10.7150/thno.1860710.7150/thno.18607 ↗
37. 10.1016/j.addr.2010.10.00810.1016/j.addr.2010.10.008 ↗
38. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
39. 10.1016/j.ceb.2007.02.00710.1016/j.ceb.2007.02.007 ↗
40. 10.1016/j.ceb.2013.01.00410.1016/j.ceb.2013.01.004 ↗
41. 10.1038/ncomms168010.1038/ncomms1680 ↗
42. 10.1021/jacs.5b0498810.1021/jacs.5b04988 ↗
43. 10.1038/nrc341910.1038/nrc3419 ↗
44. 10.1038/nature0487210.1038/nature04872 ↗
45. 10.1016/S0959-8049(00)00158-110.1016/S0959-8049(00)00158-1 ↗
46. 10.1016/j.canlet.2013.03.02710.1016/j.canlet.2013.03.027 ↗
47. 10.1038/nrc169410.1038/nrc1694 ↗
48. 10.1016/j.celrep.2012.09.01610.1016/j.celrep.2012.09.016 ↗
49. 10.1038/nature0538410.1038/nature05384 ↗
50. 10.1038/3503637410.1038/35036374 ↗
51. 10.1038/nrc323910.1038/nrc3239 ↗
52. 10.1056/NEJMoa120069410.1056/NEJMoa1200694 ↗
53. 10.1016/j.coph.2015.05.01110.1016/j.coph.2015.05.011 ↗
54. 10.1126/scitranslmed.300650410.1126/scitranslmed.3006504 ↗
55. 10.1097/CJI.000000000000006210.1097/CJI.0000000000000062 ↗
56. 10.1038/nature1440410.1038/nature14404 ↗
57. 10.1016/j.sbi.2005.06.00110.1016/j.sbi.2005.06.001 ↗
58. Zhao J.‐J. · Cancer Res. · 2014 · 74 · OF1
59. 10.1038/nrd215410.1038/nrd2154 ↗
60. 10.1073/pnas.180055011510.1073/pnas.1800550115 ↗
61. 10.1021/acsnano.8b0707910.1021/acsnano.8b07079 ↗
62. 10.1021/acs.chemmater.8b0257210.1021/acs.chemmater.8b02572 ↗
63. 10.1002/anie.20150622510.1002/anie.201506225 ↗